More than 200,000 prescriptions for copies of Novo Nordisk’s (NYSE: NVO) weight-loss drug Wegovy are getting filled by U.S. patients
1 year ago
COPENHAGEN – Novo Nordisk (NYSE: NVO) is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States
The European Medicines Agency backed the use of Novo Nordisk’s (NYSE: NVO) popular drug Wegovy to help ease heart failure
NEW YORK – On Wednesday, Hims & Hers Health (NYSE: HIMS), the U.S. telehealth company, said it will sell compounded
NEW YORK – Older Americans are having little success getting prescriptions for the weight-loss drug Wegovy covered by Medicare despite
Only one in four U.S. patients prescribed Novo Nordisk’s (NYSE: NVO) Wegovy or Ozempic for weight loss were still taking
2 years ago